Science Explorer Back to mapMap
Discussion
Institution · Hospital Ramos Mejía

Most cited papers from Hospital Ramos Mejía

Hospital Ramos Mejía

What are the most cited papers from Hospital Ramos Mejía?

The most cited paper from Hospital Ramos Mejía is "Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia" (Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al., 2010), with 1,601 citations. Next come "Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women" (913) and "Mapping and predicting mortality from systemic sclerosis" (707).

Showing 50 of 60 papers. Every paper with more than 122 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine 5 Jun 2010 1,601
2 Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women Raphael J. Landovitz et al. · New England Journal of Medicine Open access 11 Aug 2021 913
3 Mapping and predicting mortality from systemic sclerosis Muriel Elhaï et al. · Annals of the Rheumatic Diseases Open access 23 Aug 2017 707
4 Whole-genome sequencing of patients with rare diseases in a national health system Ernest Turro et al. · Nature Open access512 authors 24 Jun 2020 589
5 Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses Caroline Ovadia et al. · The Lancet Open access 14 Feb 2019 587
6 Clinical efficacy of amiodarone as an antiarrhythmic agent Mauricio Bernardo Rosenbaum, Pablo Ambrosio Chiale, M.Susana Halpern et al. · The American Journal of Cardiology Dec 1976 574
7 Adjunctive perampanel for refractory partial-onset seizures Jacqueline A. French et al. · Neurology Open access 27 Jul 2012 480
8 The Effects of Tibolone in Older Postmenopausal Women Steven Ron Cummings, Bruce B. Ettinger, Pierre Dominique Delmas et al. · New England Journal of Medicine Open access 13 Aug 2008 456
9 Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up Richard A. Larson, Andreas Hochhaus, Timothy P. Hughes et al. · Leukemia 18 May 2012 442
10 Electrotonic modulation of the T wave and cardiac memory Mauricio Bernardo Rosenbaum, Horacio H. Blanco, Marcelo Victor Elizari et al. · The American Journal of Cardiology Aug 1982 430
11 Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM Oliver A. Cornely et al. · The Lancet Infectious Diseases Open access105 authors 13 Feb 2025 392
12 Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy Jürgen Kurt Rockstroh, Amanda Mocroft, Vincent Soriano et al. · The Journal of Infectious Diseases Open access 19 Aug 2005 384
13 Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale Pablo Martínez‐Martín, Carmen Rodríguez‐Blázquez, Mario Álvarez et al. · Parkinsonism & Related Disorders Open access 5 Nov 2014 369
14 Expectation and Attention in Hierarchical Auditory Prediction Srivas Chennu, Valdas Noreika, David Gueorguiev et al. · Journal of Neuroscience Open access 3 Jul 2013 331
15 Helminth infections associated with multiple sclerosis induce regulatory B cells Jorge Daniel Correale, Mauricio Farez, Gabriela Razzitte · Annals of Neurology 24 Jul 2008 314
16 Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease Jonggeol Jeffrey Kim et al. · Nature Genetics ReviewOpen access300 authors 28 Dec 2023 286
17 Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons Colleen Frances Kelley et al. · New England Journal of Medicine 27 Nov 2024 285
18 Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Pablo Martínez‐Martín, Carmen Rodríguez‐Blázquez, Mario Álvarez et al. · Journal of Neurology 4 Aug 2012 266
19 Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. James H. Maguire, Rodney Hoff, Italo A. Sherlock et al. · Circulation Open access Jun 1987 262
20 Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride Mauricio Bernardo Rosenbaum, Pablo Ambrosio Chiale, David M. Ryba et al. · The American Journal of Cardiology Aug 1974 258
21 Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study Amanda Mocroft, AN Phillips, JM Gatell et al. · The Lancet Open access 20 Jul 2007 256
22 Functional changes in motoneurones of hemiparetic patients Alan J. McComas, Roberto E.P. Sica, Adrian R. M. Upton et al. · Journal of Neurology Neurosurgery & Psychiatry Open access Apr 1973 248
23 Neuroinflammation: An Integrating Overview of Reactive‐Neuroimmune Cell Interactions in Health and Disease Rodolfo Alberto Kölliker-Frers, Lucas Udovin, Matilde E. Otero Losada et al. · Mediators of Inflammation Open access 2021 246
24 Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test Jorge Sepulcre, Sandra Vanotti, Roberto Lagos-Hernández et al. · Multiple Sclerosis Journal Apr 2006 236
25 Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial Jesús S. Mora et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Open access 7 Jul 2019 222
26 A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy Pierre Alfred Bill, Ulf Vigonius, Harald Pohlmann et al. · Epilepsy Research Jun 1997 217
27 Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial Jörge E. Cortes et al. · Blood Open access 18 Aug 2021 203
28 Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial Michael Aboud, Richard Kaplan, Johannes Jurgens Lombaard et al. · The Lancet Infectious Diseases 4 Feb 2019 201
29 Cellular Elements of the Blood-Brain Barrier Jorge Daniel Correale, Andres Maria Villa · Neurochemical Research 24 Oct 2009 196
30 Stroke in South America Gustavo Saposnik, Óscar H. Del Brutto · Stroke Open access 12 Aug 2003 192
31 A reappraisal of Gaucher disease—diagnosis and disease management algorithms Pramod Kumar Mistry, Maria Domenica Cappellini, Elena Lukina et al. · American Journal of Hematology Open access 23 Sep 2010 192
32 Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study Jean‐Paul Viard, Jean‐Claude Souberbielle, Ole Kirk et al. · AIDS Open access 26 Apr 2011 192
33 Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus Kazima Saira, Xudong Lin, Jay V. DePasse et al. · Journal of Virology Open access 15 May 2013 187
34 Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials Alberto J. Espay, Michael A. Schwarzschild, Caroline M. Tanner et al. · Movement Disorders Open access 24 Feb 2017 186
35 Subtypes of ischemic stroke in children and young adults Linda S. Williams, Bhuwan P. Garg, M M Cohen et al. · Neurology Dec 1997 173
36 Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial Srđan Verstovšek et al. · Haematologica Open access 21 Apr 2016 163
37 Motor-language coupling: Direct evidence from early Parkinson’s disease and intracranial cortical recordings Agustín M. Ibáñez, Juan F. Cardona, Yamil Vidal et al. · Cortex Open access 8 Mar 2012 163
38 The Spectrum of Pathogenic Mutations in SPINK5 in 19 Families with Netherton Syndrome: Implications for Mutation Detection and First Case of Prenatal Diagnosis Eli Sprecher, Shivan H. Amin, Karl Nielsen et al. · Journal of Investigative Dermatology Open access Aug 2001 162
39 Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study Elena Lukina, Nora Patricia Watman, Elsa Ávila Arreguin et al. · Blood Open access 17 Aug 2010 159
40 Chagasic myocardiopathy Mauricio Bernardo Rosenbaum · Progress in Cardiovascular Diseases Nov 1964 158
41 Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis Caroline Ovadia et al. · ˜The œLancet. Gastroenterology & hepatology ReviewOpen access 27 Apr 2021 156
42 A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1 Elena Lukina, Nora Patricia Watman, Elsa Ávila Arreguin et al. · Blood Open access 4 May 2010 156
43 Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales Roxana G. Vitale, Sybren de Hoog, Patrick Schwarz et al. · Journal of Clinical Microbiology Open access 10 Nov 2011 155
44 Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer Fabián Pitoia, Laura Sterian Ward, Nelson Wohllk et al. · Arquivos Brasileiros de Endocrinologia & Metabologia Open access Oct 2009 154
45 Chronic Amiodarone Reduces Transmural Dispersion of Repolarization in the Canine Heart Serge Sicouri, SANDRA MORO, Silvio Hector Litovsky et al. · Journal of Cardiovascular Electrophysiology Nov 1997 151
46 Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma Pablo Richter, Juan C. Calamera, Marcos Carlos Morgenfeld et al. · Cancer May 1970 150
47 Hemiblocks Revisited Marcelo Victor Elizari, Rafael Salvador Acunzo, Marcela Ferreiro · Circulation 5 Mar 2007 148
48 Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study Jean‐Jacques Kiladjian et al. · The Lancet Haematology Open access 23 Jan 2020 147
49 Differences in MDS ‐ UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration Matěj Škorvánek et al. · Movement Disorders Clinical Practice Open access 24 Jan 2017 147
50 The neuroprotective role of inflammation in nervous system Injuries Jorge Daniel Correale, Andr�s Villa · Journal of Neurology Nov 2004 147

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.